{
    "Trade/Device Name(s)": [
        "Fastep\u2122 hCG Pregnancy Serum/Urine Test",
        "Fastep\u2122 hCG Pregnancy Serum/Urine Cassette Tests"
    ],
    "Submitter Information": "Polymed Therapeutics, Inc.",
    "510(k) Number": "K112101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093318",
        "K964461"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "June 20, 2012",
    "Summary Letter Received Date": "July 9, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (hCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Polymed Therapeutics Fastep\u2122 hCG Pregnancy Serum/Urine rapid chromatographic immunoassay for early pregnancy detection.",
    "Indications for Use Summary": "Visual, qualitative detection of human chorionic gonadotropin (hCG) in serum or urine to aid in early pregnancy detection for professional use at physician office labs or point-of-care sites.",
    "fda_folder": "Clinical Chemistry"
}